ETON ETON PHARMACEUTICALS INC revenue, earnings and financials
For the quarter ended June 30, 2026, ETON PHARMACEUTICALS INC reported revenue of $37.6M (up 98.6% from a year earlier), net income of $11.6M and diluted EPS of $0.35; over the last four quarters revenue was $106M and net income $12.7M; for the fiscal year ended December 2025 revenue was $80.0M, up 104.9% on the year before.
ETON annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $80.0M, gross profit $42.7M, operating income −$844K, net income −$4.60M (margin -5.8%), EPS n/a
- Fiscal year ended Dec 2024: revenue $39.0M, gross profit $23.4M, operating income −$2.60M, net income −$3.82M (margin -9.8%), EPS n/a
- Fiscal year ended Dec 2023: revenue $31.6M, gross profit $21.1M, operating income −$1.19M, net income −$936K (margin -3.0%), EPS n/a
- Fiscal year ended Dec 2022: revenue $21.3M, gross profit $14.3M, operating income −$8.26M, net income −$9.02M (margin -42.4%), EPS n/a
- Fiscal year ended Dec 2021: revenue $21.8M, gross profit $19.0M, operating income −$1.50M, net income −$1.96M (margin -9.0%), EPS −$0.08
ETON quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $37.6M (up 98.6% year over year), net income $11.6M, EPS $0.35
- Quarter ended Mar 31, 2026: revenue $24.3M (up 40.4% year over year), net income $1.55M, EPS $0.05
- Quarter ended Dec 31, 2025 (from the annual report): revenue $21.3M (up 82.7% year over year), net income $1.48M, EPS n/a
- Quarter ended Sep 30, 2025: revenue $22.5M (up 117.5% year over year), net income −$1.93M, EPS −$0.07
- Quarter ended Jun 30, 2025: revenue $18.9M (up 108.6% year over year), net income −$2.59M, EPS −$0.10
- Quarter ended Mar 31, 2025: revenue $17.3M (up 116.9% year over year), net income −$1.57M, EPS −$0.06
- Quarter ended Dec 31, 2024 (from the annual report): revenue $11.6M (up 59.3% year over year), net income −$598K, EPS n/a
- Quarter ended Sep 30, 2024: revenue $10.3M (up 46.9% year over year), net income $627K, EPS $0.02
- Quarter ended Jun 30, 2024: revenue $9.07M (down 24.4% year over year), net income −$3.04M, EPS −$0.12
- Quarter ended Mar 31, 2024: revenue $7.97M (up 50.2% year over year), net income −$811K, EPS −$0.03
- Quarter ended Dec 31, 2023 (from the annual report): revenue $7.31M (down 13.9% year over year), net income −$2.26M, EPS n/a
- Quarter ended Sep 30, 2023: revenue $7.03M (up 118.3% year over year), net income −$579K, EPS −$0.02
- Quarter ended Jun 30, 2023: revenue $12.0M (up 63.0% year over year), net income $4.56M, EPS $0.18
- Quarter ended Mar 31, 2023: revenue $5.30M (up 143.8% year over year), net income −$2.66M, EPS −$0.10
- Quarter ended Dec 31, 2022 (from the annual report): revenue $8.50M (up 39.5% year over year), net income $912K, EPS n/a
- Quarter ended Sep 30, 2022: revenue $3.22M (up 315.4% year over year), net income −$3.05M, EPS −$0.12
- Quarter ended Jun 30, 2022: revenue $7.36M (up 139.9% year over year), net income −$1.56M, EPS −$0.06
- Quarter ended Mar 31, 2022: revenue $2.18M (down 81.7% year over year), net income −$5.33M, EPS −$0.21
- Quarter ended Dec 31, 2021 (from the annual report): revenue $6.09M, net income $1.04M, EPS $0.05
- Quarter ended Sep 30, 2021: revenue $775K, net income −$6.09M, EPS −$0.24
ETON cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $10.5M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow $969K, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow $6.82M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow $4.82M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$4.72M, share buybacks n/a
ETON balance sheet
- Jun 30, 2026: cash $26.8M, total assets $116M, total liabilities $69.2M, shareholders' equity $46.6M, long-term debt $19.1M
- Mar 31, 2026: cash $19.7M, total assets $97.7M, total liabilities $67.1M, shareholders' equity $30.6M, long-term debt $18.9M
- Dec 31, 2025: cash $25.9M, total assets $92.1M, total liabilities $66.0M, shareholders' equity $26.2M, long-term debt $21.8M
- Sep 30, 2025: cash $37.1M, total assets $105M, total liabilities $81.4M, shareholders' equity $23.1M, long-term debt $27.6M
- Jun 30, 2025: cash $25.4M, total assets $102M, total liabilities $77.7M, shareholders' equity $24.0M, long-term debt $27.4M
- Mar 31, 2025: cash $17.4M, total assets $84.0M, total liabilities $59.6M, shareholders' equity $24.5M
- Dec 31, 2024: cash $14.9M, total assets $76.1M, total liabilities $51.7M, shareholders' equity $24.4M, long-term debt $29.8M
- Sep 30, 2024: cash $20.3M, total assets $35.8M, total liabilities $19.9M, shareholders' equity $16.0M
What is ETON's revenue?
ETON PHARMACEUTICALS INC reported $106M of revenue over its last four quarters, through June 30, 2026.
Is ETON profitable?
Yes. ETON PHARMACEUTICALS INC earned $12.7M over the last four quarters.